CellSource Co., Ltd.
Monthly KPI Report for May 2026 Fiscal Year
The average daily processed orders for May was 50.8, below the same month of the previous year. While demand for self-pay orthopedic procedures decreased significantly, the hybrid-type increased. Overall, Group 2's new strategy contributed to an increase in order count versus the same period last year.
Key Figures
- Average daily processed orders: 50.8
- Self-pay-focused orthopedic blood-derived processed orders: 640 (YoY -26.7%)
- Hybrid-type orthopedic blood-derived processed orders: 729 (YoY +8.2%)
AI要約
Key points of performance trends
Cellsource publishes monthly KPI for May FY2026. The average daily processed orders were 50.8, below the same month prior year, with a significant decline in self-pay-focused orthopedic procedure orders; however, hybrid-type orthopedic procedure orders rose. By group, Group 1 orders declined, but Group 2's new strategy and expanded alliances led to a substantial year-over-year increase in orders.
Outlook and strategy
Group 1 will emphasize stable operations with existing customers, while Group 2 aims to expand mid- to long-term order foundations through support for new partner clinics and utilization promotion. The company will continue to optimize the customer mix for blood-derived processed orders and strengthen the corporate administration support for medical corporate clients.
Cellsource Co., Ltd.
Company overview · Stock price · Financial data · All IR
